azithromycin · Pfizer · NDA 050670, 050693, 050710, 050711, 050730, 050733, 050784
Zithromax
Earliest generic entry, as listed · earliest of 4 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 8
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 050670 · 001 · RLD · discontinued | capsule, oral | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | open |
| 050693 · 001 · RLD · discontinued | for suspension, oral | EQ 1GM BASE/PACKET | open |
| 050710 · 001 · RLD | for suspension, oral | EQ 100MG BASE/5ML | open |
| 050710 · 002 · RLD | for suspension, oral | EQ 200MG BASE/5ML | open |
| 050711 · 001 · RLD | tablet, oral | EQ 250MG BASE | open |
| 050730 · 001 · RLD · discontinued | tablet, oral | EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | open |
| 050733 · 001 · RLD · discontinued | injectable, injection | EQ 500MG BASE/VIAL | open |
| 050784 · 001 · RLD | tablet, oral | EQ 500MG BASE | open |